[The behavior of the gonadotropins FSH and LH during and after treatment with estrogenic and progestational drugs].
D000284:Administration, Oral; D002715:Chlormadinone Acetate / Q000008:administration & dosage / Q000494:pharmacology; D004116:Dimethisterone / Q000008:administration & dosage / Q000494:pharmacology; D004338:Drug Combinations; D045166:Estradiol Congeners / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000378:metabolism*; D008656:Mestranol / Q000008:administration & dosage / Q000494:pharmacology; D009644:Norgestrel / Q000008:administration & dosage / Q000494:pharmacology; D045167:Progesterone Congeners / Q000494:pharmacology*
D004338:Drug Combinations; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D002715:Chlormadinone Acetate; D009644:Norgestrel; D004997:Ethinyl Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol; D004116:Dimethisterone
Il comportamento delle gonadotropine FSH ed LH durante e dopo trattamento con estroprogestinici. (Considerazioni cliniche)